Smith Group Asset Management’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-3,940
| Closed | -$207K | – | 342 |
|
|
2020
Q3 | $207K | Buy |
3,940
+820
| +26% | +$33.9K | 0.01% | 168 |
|
|
2020
Q2 | $104K | Sell |
3,120
-30
| -1% | -$955 | 0.01% | 195 |
|
|
2020
Q1 | $86K | Hold |
3,150
| – | – | ﹤0.01% | 222 |
|
|
2019
Q4 | $62K | Buy |
+3,150
| New | +$50.4K | ﹤0.01% | 269 |
|
|
2019
Q3 | – | Sell |
-2,210
| Closed | -$28K | – | 465 |
|
|
2019
Q2 | $28K | Hold |
2,210
| – | – | ﹤0.01% | 322 |
|
|
2019
Q1 | $32K | Sell |
2,210
-6,800
| -75% | -$86.9K | ﹤0.01% | 340 |
|
|
2018
Q4 | $99K | Buy |
+9,010
| New | +$125K | ﹤0.01% | 284 |
|
|
2015
Q4 | – | Sell |
-55,100
| Closed | -$904K | – | 527 |
|
|
2015
Q3 | $904K | Buy |
+55,100
| New | +$1.13M | 0.03% | 168 |
|
|
2015
Q1 | – | Sell |
-107,255
| Closed | -$1.29M | – | 464 |
|
|
2014
Q4 | $1.29M | Buy |
+107,255
| New | +$1.23M | 0.05% | 169 |
|
|
2013
Q3 | – | Sell |
-87,370
| Closed | -$1.32M | – | 451 |
|
|
2013
Q2 | $1.32M | Buy |
+87,370
| New | +$1.15M | 0.06% | 174 |
|
Smith Group Asset Management's MNTA Position: Q4 2020 in Review
Smith Group Asset Management sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 3,940 shares — an estimated $207K sold.
Smith Group Asset Management first reported a position in MNTA in Q2 2013 and held it in 10 quarters. The position peaked at $1.32M in Q2 2013. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.
- Smith Group Asset Management reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
- Smith Group Asset Management sold 3,940 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $207K.
- Smith Group Asset Management first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2013 and held it in 10 quarters.
- Smith Group Asset Management's Momenta Pharmaceuticals, Inc. position peaked at $1.32M in Q2 2013.
- 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.
Based on Smith Group Asset Management's 13F filing for Q4 2020, filed 9 Feb 2021.